Lapisteride

N/A

Report date: 2022/01/14 13:23:58

NME

Base Information

Drug NameLapisteride

Drug Alias Namelapisterida拉匹雄胺lapisteridumCS-891CS-891B

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionSteroid 5 alpha reductase inhibitors

TargetsSteroid 5 alpha reductase

Therapy Area/IndicationsAlopeciaProstatic Hyperplasia

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusDiscontinued (Phase 2 Clinical)

Highest Status in ChinaN/A

China Registration ClassN/A

Active CompaniesN/A

Active IndicationsN/A

Inactive IndicationsAlopeciaProstatic Hyperplasia

ATC CodeN/A